We are taking the threat of COVID-19 very seriously. Click here to find out what our firm is doing.
Law Office of Cohen & Jaffe, LLP

Indicators of Zantac-Related Cancer

Many people who experience acid reflux and heartburn are familiar with the Zantac warning that first appeared in 2019. These dangers involve N-nitrosodimethylamine (NDMA), which is a cancer-causing chemical agent found in Zantac, the generic name for which is ranitidine.

While Zantac and many ranitidine-containing medications have recently been recalled, it is still important for people to recognize the signs and symptoms of cancer caused by Zantac and other ranitidine-containing medications.

Potential Cancer Signs

The World Health Organization (WHO) as well as the Food and Drug Administration (FDA) have reported that NDMA-containing medications can cause colon and rectal cancer in people who consume a large volume of the medication over an extended period. Consequently, it is a good idea for people to speak with their physician if they have regularly taken medications containing ranitidine. You might also want to request a test for stomach cancer.

Some of the most common indicators that a person has colorectal cancer include:

  • Anemia associated with intestinal bleeding
  • Cramps, gas, and pain in the abdomen
  • Fatigue or weakness
  • Never feeling empty, even after defecating
  • Sudden changes in bowel movements, which might include constipation or diarrhea
  • Unexpected weight loss

Testing Options for At-Risk Individuals

There are several screening options to assess both a person’s risk of Zantac-related cancer as well as diagnostics to determine the presence of cancer in a person’s body. These options include:

  • Family history. Many patients are at greater risk of colorectal or gastric cancer as a result of their family history. Consequently, an assessment of a person’s family history and whether any family members have been diagnosed with colon cancer to estimate a person’s cancer risks.
  • Once a physician has performed other tests and believes that a person might have colon cancer, a biopsy of the individual’s colon will be performed. After material is removed from a person’s colon, it is sent to a laboratory for analysis to determine if the sample is cancerous.
  • Blood tests. There is no 100% reliable way to detect cancer, but one of the most tests by medical professionals used to detect cancer are blood tests. In the case of colon cancer, blood tests look for the presence of a chemical known as carcinoembryonic antigen (CEA).
  • CT scans. A patient who has already been diagnosed with colorectal cancer might receive a CT scan to determine if the cancer has metastasized to other parts of the patient’s body.
  • Magnetic resonance imaging (MRI) is considered one of the most reliable tests for detecting colorectal cancer, which is why it is commonly employed in these situations.

Speak with a Zantac Attorney Today

Remember that if you are not sure that a medication is safe, check for the generic name “ranitidine” on the medication’s label. If you have been taking Zantac for some time, however, you should not hesitate to speak with a medical professional if you notice signs and symptoms of cancer. Blood tests often play a critical role in helping people determine whether they have cancer. After taking care of your health, you should not hesitate to speak with a knowledgeable attorney at Cohen & Jaffe LLP. Scheulde your free consultation for your Zantac lawsuit today.


Subscribe to Our Newsletter

Trusted & Respected